The islet β-cell: fuel responsive and vulnerable

Trends in Endocrinology and Metabolism

Volumn 19, Issue 8, 2008, Pages 285-291

  Nolan, Christopher J ^a   Prentki, Marc ^b  

^a CANBERRA HOSPITAL   (Australia)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; FATTY ACID; GLUCOSE; GLYCEROLIPID;

CELL FUNCTION; DETOXIFICATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INSULIN RELEASE; NONHUMAN; NUTRIENT SUPPLY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

AMINO ACIDS; ANIMALS; ENERGY METABOLISM; FATTY ACIDS; FOOD; GLUCOSE; HUMANS; INSULIN-SECRETING CELLS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; PANCREATIC DISEASES;

EID: 52249114681     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.07.006     Document Type: Review

References (70)

1. Prentki M., and Nolan C.J. Islet beta cell failure in type 2 diabetes. J. Clin. Invest. 116 (2006) 1802-1812
2. Wickremesekera K., et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes. Surg. 15 (2005) 474-481
3. Prentki M. New insights into pancreatic beta-cell metabolic signaling in insulin secretion. Eur. J. Endocrinol. 134 (1996) 272-286
4. Meglasson M.D., and Matschinsky F.M. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab. Rev. 2 (1986) 163-214
5. Newgard C.B., and Mcgarry J.D. Metabolic coupling factors in pancreatic beta-cell signal transduction. Annu. Rev. Biochem. 64 (1995) 689-719
6. Nolan C.J., et al. Fatty acid signaling in the β-cell and insulin secretion. Diabetes 55 Suppl 2 (2006) S16-S23
7. Roduit R., et al. A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. Diabetes 53 (2004) 1007-1019
8. Newsholme P., et al. Amino acid metabolism, insulin secretion and diabetes. Biochem. Soc. Trans. 35 (2007) 1180-1186
9. Drucker D.J. The biology of incretin hormones. Cell Metab. 3 (2006) 153-165
10. Ahren B. Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 43 (2000) 393-410
11. Ashcroft F.M., and Rorsman P. ATP-sensitive K+ channels: a link between B-cell metabolism and insulin secretion. Biochem. Soc. Trans. 18 (1990) 109-111
12. Eto K., et al. Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 283 (1999) 981-985
13. Schuit F., et al. Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J. Biol. Chem. 272 (1997) 18572-18579
14. Kibbey R.G., et al. Mitochondrial GTP regulates glucose-stimulated insulin secretion. Cell Metab. 5 (2007) 253-264
15. Pi J., et al. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 56 (2007) 1783-1791
16. Flamez D., et al. Critical role for cataplerosis via citrate in glucose-regulated insulin release. Diabetes 51 (2002) 2018-2024
17. Prentki M., and Corkey B.E. Are the beta-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?. Diabetes 45 (1996) 273-283
18. Guay C., et al. A role for ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-induced insulin secretion. J. Biol. Chem. 282 (2007) 35657-35665
19. Ronnebaum S.M., et al. A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J. Biol. Chem. 281 (2006) 30593-30602
20. Joseph J.W., et al. The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion. J. Biol. Chem. 281 (2006) 35624-35632
21. Pongratz R.L., et al. Cytosolic and mitochondrial malic enzyme isoforms differentially control insulin secretion. J. Biol. Chem. 282 (2007) 200-207
22. Macdonald M.J. Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets. Further implication of cytosolic NADPH in insulin secretion. J. Biol. Chem. 270 (1995) 20051-20058
23. Lu D., et al. 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2708-2713
24. Cline G.W., et al. 13C NMR isotopomer analysis of anaplerotic pathways in INS-1 cells. J. Biol. Chem. 279 (2004) 44370-44375
25. Ivarsson R., et al. Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54 (2005) 2132-2142
26. Farfari S., et al. Glucose regulated anaplerosis and cataplerosis in pancreatic β-cells. Possible implication of a pyruvate/citrate shuttle in insulin secretion. Diabetes 49 (2000) 718-726
27. Maechler P., and Wollheim C.B. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402 (1999) 685-689
28. Macdonald M.J., and Fahien L.A. Glutamate is not a messenger in insulin secretion. J. Biol. Chem. 275 (2000) 34025-34027
29. Nolan C.J., et al. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling. Diabetologia 49 (2006) 2120-2130
30. Bender K., et al. The importance of redox shuttles to pancreatic beta-cell energy metabolism and function. Biochem. Soc. Trans. 34 (2006) 811-814
31. Macdonald M.J., and Marshall L.K. Survey of normal appearing mouse strain which lacks malic enzyme and Nad+-linked glycerol phosphate dehydrogenase: normal pancreatic beta cell function, but abnormal metabolite pattern in skeletal muscle. Mol. Cell. Biochem. 220 (2001) 117-125
32. Metz S.A. Lysophosphatidylinositol, but not lysophosphatidic acid, stimulates insulin release. A possible role for phospholipase A2 but not de novo synthesis of lysophospholipid in pancreatic islet function. Biochem. Biophys. Res. Commun. 138 (1986) 720-727
33. Nenquin M., et al. Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells. J. Biol. Chem. 279 (2004) 32316-32324
34. Sener A., and Malaisse W.J. The stimulus-secretion coupling of amino acid-induced insulin release. Insulinotropic action of L-alanine. Biochim. Biophys. Acta 1573 (2002) 100-104
35. Mcclenaghan N.H., et al. Na+ cotransport by metabolizable and nonmetabolizable amino acids stimulates a glucose-regulated insulin-secretory response. Biochem. Biophys. Res. Commun. 249 (1998) 299-303
36. Sener A., and Malaisse W.J. L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 288 (1980) 187-189
37. Stein D.T., et al. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J. Clin. Invest. 97 (1996) 2728-2735
38. Corkey B.E., et al. The role of long-chain fatty acyl-CoA esters in beta-cell signal transduction. J. Nutr. 130 (2000) 299S-304S
39. Mulder H., et al. Inhibition of lipase activity and lipolysis in rat islets reduces insulin secretion. Diabetes 53 (2004) 122-128
40. Peyot M.L., et al. Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1. Diabetes 53 (2004) 1733-1742
41. Itoh Y., et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422 (2003) 173-176
42. Latour M.G., et al. GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo. Diabetes 56 (2007) 1087-1094
43. Kebede M., et al. The fatty-acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding. Diabetes (2008) 10.2337/db08-0553
44. Shapiro H., et al. Role of GPR40 in fatty acid action on the beta cell line INS-1E. Biochem. Biophys. Res. Commun. 335 (2005) 97-104
45. Martins E.F., et al. Changes of fatty acid composition in incubated rat pancreatic islets. Diabetes Metab. 30 (2004) 21-27
46. Gremlich S., et al. Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation. Endocrinology 146 (2005) 375-382
47. Hu L., et al. Regulation of lipolytic activity by long-chain acyl-coenzyme A in islets and adipocytes. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E1085-E1092
48. Vannucci S.J., et al. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21 (1997) 2-21
49. Kraegen E.W., et al. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. Exp. Clin. Endocrinol. Diabetes 109 (2001) S189-S201
50. Krebs M., and Roden M. Nutrient-induced insulin resistance in human skeletal muscle. Curr. Med. Chem. 11 (2004) 901-908
51. Tremblay F., et al. Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu. Rev. Nutr. 27 (2007) 293-310
52. Liu Y.Q., et al. beta-Cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats. J. Biol. Chem. 277 (2002) 39163-39168
53. El-Assaad W., et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144 (2003) 4154-4163
54. Brownlee M. A radical explanation for glucose-induced beta cell dysfunction. J. Clin. Invest. 112 (2003) 1788-1790
55. Poitout V., and Robertson R.P. Minireview: Secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology 143 (2002) 339-342
56. Tonooka N., et al. Glutathione peroxidase protein expression and activity in human islets isolated for transplantation. Clin. Transplant. 21 (2007) 767-772
57. Coleman R.A., et al. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways?. J. Nutr. 132 (2002) 2123-2126
58. Lameloise N., et al. Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion?. Diabetes 50 (2001) 803-809
59. Joseph J.W., et al. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51 (2002) 3211-3219
60. Ruderman N., and Prentki M. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat. Rev. Drug Discov. 3 (2004) 340-351
61. Winder W.W., and Hardie D.G. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277 (1999) E1-E10
62. Muoio D.M., et al. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem. J. 338 (1999) 783-791
63. Cnop M., et al. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50 (2001) 1771-1777
64. Busch A.K., et al. Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic beta-cells from lipoapoptosis. Diabetes 54 (2005) 2917-2924
65. Przybytkowski E., et al. Upregulation of cellular triacylglycerol - free fatty acid cycling by oleate is associated with long-term serum-free survival of human breast cancer cells. Biochem. Cell Biol. 85 (2007) 301-310
66. Sladek R., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
67. Griffen S.C., et al. A genetic defect in beta-cell gene expression segregates independently from the fa locus in the ZDF rat. Diabetes 50 (2001) 63-68
68. Ohneda M., et al. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia 38 (1995) 173-179
69. Pold R., et al. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54 (2005) 928-934
70. Frayling T.M. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat. Rev. Genet. 8 (2007) 657-662